Imatinib Mesylate. STI-571 is another name for Imatinib Mesylate. The free base is marketed by Novartis under the name Gleevec or Glivec. Imatinib Mesylate is a targeted therapy. Imatinib Mesylate is classified as a signal transduction inhibitor – protein-tyrosine kinase inhibitor.
Cancer Research and Antivirals
|Formula||C29H31N7O · CH4O3S|
Send us your enquiry for Imatinib Mesylate. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Imatinib Mesylate email us and we will include your contribution on the website.